1. Home
  2. KROS vs MUX Comparison

KROS vs MUX Comparison

Compare KROS & MUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • MUX
  • Stock Information
  • Founded
  • KROS 2015
  • MUX 1979
  • Country
  • KROS United States
  • MUX Canada
  • Employees
  • KROS N/A
  • MUX N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • MUX Precious Metals
  • Sector
  • KROS Health Care
  • MUX Basic Materials
  • Exchange
  • KROS Nasdaq
  • MUX Nasdaq
  • Market Cap
  • KROS 565.0M
  • MUX 579.8M
  • IPO Year
  • KROS 2020
  • MUX N/A
  • Fundamental
  • Price
  • KROS $14.51
  • MUX $10.83
  • Analyst Decision
  • KROS Buy
  • MUX Strong Buy
  • Analyst Count
  • KROS 13
  • MUX 2
  • Target Price
  • KROS $20.63
  • MUX $15.25
  • AVG Volume (30 Days)
  • KROS 450.7K
  • MUX 864.1K
  • Earning Date
  • KROS 08-06-2025
  • MUX 08-06-2025
  • Dividend Yield
  • KROS N/A
  • MUX N/A
  • EPS Growth
  • KROS N/A
  • MUX N/A
  • EPS
  • KROS 0.11
  • MUX N/A
  • Revenue
  • KROS $214,713,000.00
  • MUX $168,945,000.00
  • Revenue This Year
  • KROS $5,390.70
  • MUX $1.09
  • Revenue Next Year
  • KROS N/A
  • MUX N/A
  • P/E Ratio
  • KROS $133.17
  • MUX N/A
  • Revenue Growth
  • KROS 91657.70
  • MUX N/A
  • 52 Week Low
  • KROS $9.12
  • MUX $6.38
  • 52 Week High
  • KROS $72.37
  • MUX $11.80
  • Technical
  • Relative Strength Index (RSI)
  • KROS 58.66
  • MUX 53.42
  • Support Level
  • KROS $14.18
  • MUX $10.72
  • Resistance Level
  • KROS $14.85
  • MUX $11.80
  • Average True Range (ATR)
  • KROS 0.55
  • MUX 0.40
  • MACD
  • KROS 0.04
  • MUX -0.07
  • Stochastic Oscillator
  • KROS 71.78
  • MUX 32.64

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About MUX McEwen Mining Inc.

McEwen Inc, formerly McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, majority of production occurs in the United States.

Share on Social Networks: